Melanoma Cancer section

Melanoma News & Features

Mortality rates not increased in pregnancy-associated malignant melanoma

Mortality rates not increased in pregnancy-associated malignant melanoma

Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.

Key discovery in understanding successes and failures of immunotherapy

Key discovery in understanding successes and failures of immunotherapy

A key discovery has advanced the understanding of why some patients respond to ipilimumab, an immunotherapy drug, whereas others show less response.

Combination treatments show promise for metastatic melanoma

Combination treatments show promise for metastatic melanoma

Nivolumab and dabrafenib plus trametinib up survival in melanoma without, with BRAF, respectively.

TNF-alpha inhibitors associated with uveal melanoma

TNF-alpha inhibitors associated with uveal melanoma

There may be a correlation between tumor necrosis factor (TNF)-alpha inhibitors and the development of uveal melanoma.

Combination treatment for metastatic melanoma results in longer overall survival

Treatment with a combination of the drugs sargramostim plus ipilimumab, rather than ipilimumab alone, yielded longer overall survival and lower toxicity for patients with metastatic melanoma.

Melanoma Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs